This individual participant data meta-analysis assesses treatment time from stroke symptom onset and disability level after treatment with intravenous thromboly
Mechanical thrombectomy is a ground breaking treatment for acute ischaemic stroke caused by occlusion of a large vessel. Its efficacy over intravenous thrombolysis has been proven in multiple trials with a lower number needed to treat than percutaneous coronary intervention for acute myocardial infarction. However, access to this key treatment modality remains limited with a considerable postcode lottery across the UK and many parts of the world. The evidence base for mechanical thrombectomy dates back to 2015. Since then, there have been important advances in establishing and widening the criteria for treatment. This narrative review aims to summarise the current evidence base and latest advances for physicians and academics with an interest in recanalisation treatments for acute ischaemic stroke.
Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
In this study, endovascular treatment was efficacious and safe for patients with ischaemic
stroke caused by an anterior circulation large-vessel occlusion who presented 6–24
h from onset or last seen well, and who were selected on the basis of the presence
of collateral flow on CTA. Selection of patients for endovascular treatment in the
late window could be primarily based on the presence of collateral flow.
For World Stroke Day 2022, News-Medical speaks to Dr. Patrick Brouwer, Head of Worldwide Medical Affairs at CERENOVUS, about why saving #Precioustime is critical when it comes to recognizing and seeking medical treatment for stroke.